| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc319b4978312a8689e03a1669d3905c |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 |
| filingDate |
1993-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_609fe74eed35bba31d52cf35e20e7e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45d5fac6b876cdcdb9893e20f07f445 |
| publicationDate |
1997-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2077321-C1 |
| titleOfInvention |
Method of paranoid schizophrenia acute attack arresting |
| abstract |
FIELD: medicine, psychiatry. SUBSTANCE: method involves intramuscular administration of neuroleptics of the prolonged action. Week dose of haloperidol decanoate and piportil L4 is 200-300 mg, clopixol depot - 600-800 mg, treatment course - 3-6 injections. EFFECT: enhanced effectiveness of treatment. |
| priorityDate |
1993-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |